These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16208494)

  • 1. Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand.
    Najajreh Y; Kasparkova J; Marini V; Gibson D; Brabec V
    J Biol Inorg Chem; 2005 Nov; 10(7):722-31. PubMed ID: 16208494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
    Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
    Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action.
    Kasparkova J; Novakova O; Marini V; Najajreh Y; Gibson D; Perez JM; Brabec V
    J Biol Chem; 2003 Nov; 278(48):47516-25. PubMed ID: 12970368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
    Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J
    Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J; Novakova O; Farrell N; Brabec V
    Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization, DNA interactions, and cytotoxicity of new transplatin analogues containing one aliphatic and one planar heterocyclic amine ligand.
    Ramos-Lima FJ; Vrána O; Quiroga AG; Navarro-Ranninger C; Halámiková A; Rybnícková H; Hejmalová L; Brabec V
    J Med Chem; 2006 Apr; 49(8):2640-51. PubMed ID: 16610807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel apoptosis-inducing trans-platinum piperidine derivatives: synthesis and biological characterization.
    Khazanov E; Barenholz Y; Gibson D; Najajreh Y
    J Med Chem; 2002 Nov; 45(24):5196-204. PubMed ID: 12431047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The induction of lysis in lysogenic strains of Escherichia coli by a new antitumor transplatin derivative and its DNA interactions.
    Brabec V; Pracharova J; Novakova O; Gibson D; Kasparkova J
    Dalton Trans; 2015 Feb; 44(8):3573-82. PubMed ID: 25406573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues.
    Kasparkova J; Novakova O; Najajreh Y; Gibson D; Perez JM; Brabec V
    Chem Res Toxicol; 2003 Nov; 16(11):1424-32. PubMed ID: 14615968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand.
    Frybortova M; Novakova O; Stepankova J; Novohradsky V; Gibson D; Kasparkova J; Brabec V
    J Inorg Biochem; 2013 Sep; 126():46-54. PubMed ID: 23770803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)].
    Zákovská A; Nováková O; Balcarová Z; Bierbach U; Farrell N; Brabec V
    Eur J Biochem; 1998 Jun; 254(3):547-57. PubMed ID: 9688265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA modifications by antitumor trans-[PtCl2(E-iminoether)2].
    Zaludová R; Zákovská A; Kaspárkova J; Balcarová Z; Vrána O; Coluccia M; Natile G; Brabec V
    Mol Pharmacol; 1997 Sep; 52(3):354-61. PubMed ID: 9281596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.
    Novakova O; Kasparkova J; Malina J; Natile G; Brabec V
    Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stability of DNA intrastrand cross-links of antitumor transplatin derivative containing non-bulky methylamine ligands.
    Frybortova M; Novakova O; Brabec V
    J Biol Inorg Chem; 2014 Oct; 19(7):1203-8. PubMed ID: 24986778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.
    Zhao Y; Woods JA; Farrer NJ; Robinson KS; Pracharova J; Kasparkova J; Novakova O; Li H; Salassa L; Pizarro AM; Clarkson GJ; Song L; Brabec V; Sadler PJ
    Chemistry; 2013 Jul; 19(29):9578-91. PubMed ID: 23733242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligand.
    Prokop R; Kasparkova J; Novakova O; Marini V; Pizarro AM; Navarro-Ranninger C; Brabec V
    Biochem Pharmacol; 2004 Mar; 67(6):1097-109. PubMed ID: 15006546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformation, protein recognition and repair of DNA interstrand and intrastrand cross-links of antitumor trans-[PtCl2(NH3)(thiazole)].
    Marini V; Christofis P; Novakova O; Kasparkova J; Farrell N; Brabec V
    Nucleic Acids Res; 2005; 33(18):5819-28. PubMed ID: 16237123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steric control of DNA interstrand cross-link sites of trans platinum complexes: specificity can be dictated by planar nonleaving groups.
    Brabec V; Neplechova K; Kasparkova J; Farrell N
    J Biol Inorg Chem; 2000 Jun; 5(3):364-8. PubMed ID: 10907747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2].
    Brabec V; Vrána O; Nováková O; Kleinwächter V; Intini FP; Coluccia M; Natile G
    Nucleic Acids Res; 1996 Jan; 24(2):336-41. PubMed ID: 8628659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacement of an NH(3) by an iminoether in transplatin makes an antitumor drug from an inactive compound.
    Leng M; Locker D; Giraud-Panis MJ; Schwartz A; Intini FP; Natile G; Pisano C; Boccarelli A; Giordano D; Coluccia M
    Mol Pharmacol; 2000 Dec; 58(6):1525-35. PubMed ID: 11093793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.